• 14TH JUNE 2022

    Supplies made in accordance with HRT SSPs – FAQ briefing and top tips

    Following the Department of Health and Social Care’s (DHSC) announcement of three new Serious Shortage Protocols (SSPs) for Hormone Replacement Therapy (HRT) medicines, PSNC has created a briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ to help pharmacists understand the requirements of these SSPs. In addition, to support pharmacy teams, PSNC has also put together some helpful

    Read more
    • 14TH JUNE 2022

    Strengthening the Sector: A video message from PSNC’s CEO

    PSNC Chief Executive Janet Morrison has recorded a video message for community pharmacy contractors about her personal reflections on the proposals for the future of PSNC and LPCs made by the Pharmacy Representation Review Steering Group (RSG). In the video, Janet recognises the proposals as sensible and practical steps that any modern and forward-thinking sector

    Read more
    • 14TH JUNE 2022

    Contractor Notice: Extended FP34C submission deadline for prescriptions dispensed in May 2022

    Contractors will have until the 7 June 2022 to submit their FP34C declaration through the Manage Your Service (MYS) portal for NHS pharmaceutical services delivered in May 2022. Normally, if one or more bank holiday occurs within the first five days of the month, contractors are given an extra day to complete their monthly submissions.

    Read more
    • 14TH JUNE 2022

    HEE: Clinical Skills Training Survey

    Health Education England (HEE) are seeking the views of frontline community pharmacists to support the development of further training modules that support pharmacists in the provision of NHS community pharmacy services across England. HEE are working closely with NHS England and NHS Improvement to provide these training opportunities. Since 2019, the Centre for Pharmacy Postgraduate Education and the Royal Pharmaceutical

    Read more
    • 14TH JUNE 2022

    England’s new Chief Pharmaceutical Officer praises the work of community pharmacy

    The recently appointed Chief Pharmaceutical Officer (CPhO) for England, David Webb, delivered a keynote speech in person at the National Meeting of LPCs and PSNC on Thursday 17th May 2022. As the new head of the pharmacy professions, he set out his personal priorities for the next few years. At the start of his speech,

    Read more
    • 14TH JUNE 2022

    PSNC submits response to Hub and Spoke consultation

    PSNC has submitted its response to the proposals set out in the Department of Health and Social Care’s (DHSC’s) consultation on hub and spoke dispensing. The consultation proposes making legislative changes to allow the operation of hub and spoke dispensing across different legal entities, and proposes to introduce two different models for this. Model 1

    Read more
    • 9TH JUNE 2022

    Hypertension Case-Finding Service highlighted in RCGP C-19 recovery guidance

    As part of recovery plans following COVID-19, the Royal College of General Practitioners (RCGP) has produced guidance for clinicians working in general practice, which sets out suggested actions for consideration to support long-term condition management over the next six months. Among the suggestions is for clinicians to consider signposting patients with cardiovascular disease to the

    Read more
    • 31ST MAY 2022

    New SSPs issued for Lipitor® 10mg chewable tablets and Paracetamol 120mg suppositories

    In response to a significant ongoing disruption to the supply affecting Lipitor® 10mg chewable tablets and Paracetamol 120mg suppositories, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). SSP 032 – Lipitor® 10mg  chewable tablets Effective today, 31 May 2022, SSP032 provides that for every Lipitor® 10mg chewable tablet

    Read more
    • 31ST MAY 2022

    One pump daily dose conversion added to Oestrogel®SSPs

    The Department of Health and Social Care (DHSC) has updated Annex A of SSP022 and SSP023 for Oestrogel® Pump-Pack 0.06% gel to include a dose conversion to a specific alternative Estradiol patch for patients who use 1 pump of Oestrogel® daily. Previously, only dose conversions for patients using 2 to 4 pumps daily were included in Annex A of SSP022

    Read more
    • 12TH MAY 2022

    Over 10,700 contractors benefit from earlier advance payments on 12 May

    10,797 pharmacy contractors who declared their April 2022 FP34C submission figures through the Manage Your Service (MYS) portal by 6 May 2022 received their earlier advance payments on Thursday 12 May 2022 (circa 20 days earlier than the normal advance payment timetable). This leaves c.400 contractors who did not receive any earlier advance payments in

    Read more